Open Access

[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2

  • Authors:
    • Loredana Moro
    • Arnaldo A. Arbini
    • Ersilia Marra
    • Margherita Greco
  • View Affiliations

  • Published online on: April 14, 2016     https://doi.org/10.3892/ijo.2016.3487
  • Pages: 2722-2722
  • Copyright: © Moro et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

June-2016
Volume 48 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Moro L, Arbini AA, Marra E and Greco M: [Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. Int J Oncol 48: 2722-2722, 2016.
APA
Moro, L., Arbini, A.A., Marra, E., & Greco, M. (2016). [Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. International Journal of Oncology, 48, 2722-2722. https://doi.org/10.3892/ijo.2016.3487
MLA
Moro, L., Arbini, A. A., Marra, E., Greco, M."[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2". International Journal of Oncology 48.6 (2016): 2722-2722.
Chicago
Moro, L., Arbini, A. A., Marra, E., Greco, M."[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2". International Journal of Oncology 48, no. 6 (2016): 2722-2722. https://doi.org/10.3892/ijo.2016.3487